NEW YORK (GenomeWeb News) – Cepheid is asking a federal court to declare two patents held by Roche invalid.

In a lawsuit filed last week in the US District Court for the Northern District of California, Cepheid asked the court also to find that it does not infringe US Patent Nos. 5,804,375 and 6,127,155 held by Roche.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.